These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16772406)

  • 21. Human hyalohyphomycoses: a review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp.
    Schinabeck MK; Ghannoum MA
    J Chemother; 2003 Nov; 15 Suppl 2():5-15. PubMed ID: 14708962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections.
    Lewis RE
    Am J Ther; 2012 Jan; 19(1):51-63. PubMed ID: 21248618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to select an antifungal agent in critically ill patients.
    Dimopoulos G; Antonopoulou A; Armaganidis A; Vincent JL
    J Crit Care; 2013 Oct; 28(5):717-27. PubMed ID: 24018296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
    Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Fungal Endophthalmitis Associated with Cataract Surgery: A Mini-Review.
    Smith TC; Benefield RJ; Kim JH
    Mycopathologia; 2015 Dec; 180(5-6):291-7. PubMed ID: 26318595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal therapy in invasive fungal infections.
    Chen SC; Playford EG; Sorrell TC
    Curr Opin Pharmacol; 2010 Oct; 10(5):522-30. PubMed ID: 20598943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voriconazole: therapeutic review of a new azole antifungal.
    Herbrecht R
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.
    Walsh TJ; Hiemenz JW; Anaissie E
    Infect Dis Clin North Am; 1996 Jun; 10(2):365-400. PubMed ID: 8803625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
    Perlroth J; Choi B; Spellberg B
    Med Mycol; 2007 Jun; 45(4):321-46. PubMed ID: 17510856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope
    Stemler J; Salmanton-García J; Seidel D; Alexander BD; Bertz H; Hoenigl M; Herbrecht R; Meintker L; Meißner A; Mellinghoff SC; Sal E; Zarrouk M; Koehler P; Cornely OA
    Mycoses; 2020 Mar; 63(3):265-274. PubMed ID: 31769549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genitourinary fungal infections: a therapeutic conundrum.
    Wise GJ
    Expert Opin Pharmacother; 2001 Aug; 2(8):1211-26. PubMed ID: 11584989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging and less common fungal pathogens.
    Fleming RV; Walsh TJ; Anaissie EJ
    Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of rare fungal infections.
    Al-Abdely HM
    Curr Opin Infect Dis; 2004 Dec; 17(6):527-32. PubMed ID: 15640706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of clinical filamentous fungi in Qatar beyond Aspergillus and Fusarium with notes on the rare species.
    Salah H; Houbraken J; Boekhout T; Almaslamani M; Taj-Aldeen SJ
    Med Mycol; 2022 Dec; 61(1):. PubMed ID: 36592959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of invasive fungal infections: Molecular epidemiology, etiology, clinical conditions, diagnosis and risk factors: A 3-year experience with 490 patients under intensive care.
    Borjian Boroujeni Z; Shamsaei S; Yarahmadi M; Getso MI; Salimi Khorashad A; Haghighi L; Raissi V; Zareei M; Saleh Mohammadzade A; Moqarabzadeh V; Soleimani A; Raeisi F; Mohseni M; Mohseni MS; Raiesi O
    Microb Pathog; 2021 Mar; 152():104616. PubMed ID: 33212195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current challenges in the management of invasive fungal infections.
    Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
    J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.